{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T03:50:50Z","timestamp":1780458650026,"version":"3.54.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2003,9,21]],"date-time":"2003-09-21T00:00:00Z","timestamp":1064102400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2003,10]]},"DOI":"10.1038\/nm934","type":"journal-article","created":{"date-parts":[[2003,9,22]],"date-time":"2003-09-22T10:14:51Z","timestamp":1064225691000},"page":"1269-1274","source":"Crossref","is-referenced-by-count":1905,"title":["Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase"],"prefix":"10.1038","volume":"9","author":[{"given":"Catherine","family":"Uyttenhove","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Pilotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Th\u00e9ate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Stroobant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Colau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Parmentier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Boon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beno\u00eet J","family":"Van den Eynde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2003,9,21]]},"reference":[{"key":"BFnm934_CR1","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/S0167-5699(99)01520-0","volume":"20","author":"AL Mellor","year":"1999","unstructured":"Mellor, A.L. & Munn, D.H. Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation? Immunol. Today 20, 469\u2013473 (1999).","journal-title":"Immunol. Today"},{"key":"BFnm934_CR2","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1126\/science.281.5380.1191","volume":"281","author":"DH Munn","year":"1998","unstructured":"Munn, D.H. et al. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 281, 1191\u20131193 (1998).","journal-title":"Science"},{"key":"BFnm934_CR3","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1084\/jem.189.9.1363","volume":"189","author":"DH Munn","year":"1999","unstructured":"Munn, D.H. et al. Inhibition of T cell proliferation by macrophage tryptophan catabolism. J. Exp. Med. 189, 1363\u20131372 (1999).","journal-title":"J. Exp. Med."},{"key":"BFnm934_CR4","doi-asserted-by":"publisher","first-page":"3596","DOI":"10.4049\/jimmunol.164.7.3596","volume":"164","author":"P Hwu","year":"2000","unstructured":"Hwu, P. et al. Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation. J. Immunol. 164, 3596\u20133599 (2000).","journal-title":"J. Immunol."},{"key":"BFnm934_CR5","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/j.1469-7793.2001.00207.x","volume":"535","author":"Y Kudo","year":"2001","unstructured":"Kudo, Y., Boyd, C.A., Sargent, I.L. & Redman, C.W. Tryptophan degradation by human placental indoleamine 2,3-dioxygenase regulates lymphocyte proliferation. J. Physiol. 535, 207\u2013215 (2001).","journal-title":"J. Physiol."},{"key":"BFnm934_CR6","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/S0041-1345(00)02078-9","volume":"33","author":"G Frumento","year":"2001","unstructured":"Frumento, G., Rotondo, R., Tonetti, M. & Ferrara, G.B. T cell proliferation is blocked by indoleamine 2,3-dioxygenase. Transplant. Proc. 33, 428\u2013430 (2001).","journal-title":"Transplant. Proc."},{"key":"BFnm934_CR7","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1093\/intimm\/14.1.65","volume":"14","author":"F Fallarino","year":"2002","unstructured":"Fallarino, F. et al. Functional expression of indoleamine 2,3-dioxygenase by murine CD8\u03b1+ dendritic cells. Int. Immunol. 14, 65\u201368 (2002).","journal-title":"Int. Immunol."},{"key":"BFnm934_CR8","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1016\/S0021-9258(19)77982-4","volume":"263","author":"O Takikawa","year":"1988","unstructured":"Takikawa, O., Kuroiwa, T., Yamazaki, F. & Kido, R. Mechanism of interferon-gamma action. Characterization of indoleamine 2,3-dioxygenase in cultured human cells induced by interferon-gamma and evaluation of the enzyme-mediated tryptophan degradation in its anticellular activity. J. Biol. Chem. 263, 2041\u20132046 (1988).","journal-title":"J. Biol. Chem."},{"key":"BFnm934_CR9","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/0378-1119(91)90154-4","volume":"105","author":"A Habara-Ohkubo","year":"1991","unstructured":"Habara-Ohkubo, A., Takikawa, O. & Yoshida, R. Cloning and expression of a cDNA encoding mouse indoleamine 2,3- dioxygenase. Gene 105, 221\u2013227 (1991).","journal-title":"Gene"},{"key":"BFnm934_CR10","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1126\/science.1073514","volume":"297","author":"DH Munn","year":"2002","unstructured":"Munn, D.H. et al. Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase. Science 297, 1867\u20131870 (2002).","journal-title":"Science"},{"key":"BFnm934_CR11","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/ijc.10645","volume":"101","author":"M Friberg","year":"2002","unstructured":"Friberg, M. et al. Indoleamine 2,3-dioxygenase contributes to tumor cell evasion of T cell-mediated rejection. Int. J. Cancer 101, 151\u2013155 (2002).","journal-title":"Int. J. Cancer"},{"key":"BFnm934_CR12","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1038\/ni846","volume":"3","author":"U Grohmann","year":"2002","unstructured":"Grohmann, U. et al. CTLA-4-Ig regulates tryptophan catabolism in vivo. Nature Immunol. 3, 1097\u20131101 (2002).","journal-title":"Nature Immunol."},{"key":"BFnm934_CR13","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1084\/jem.173.6.1373","volume":"173","author":"B Van den Eynde","year":"1991","unstructured":"Van den Eynde, B., Leth\u00e9, B., Van Pel, A., De Plaen, E. & Boon, T. The gene coding for a major tumor rejection antigen of tumor P815 is identical to the normal gene of syngeneic DBA\/2 mice. J. Exp. Med. 173, 1373\u20131384 (1991).","journal-title":"J. Exp. Med."},{"key":"BFnm934_CR14","doi-asserted-by":"publisher","first-page":"4010","DOI":"10.1002\/(SICI)1521-4141(199812)28:12<4010::AID-IMMU4010>3.0.CO;2-5","volume":"28","author":"D Br\u00e4ndle","year":"1998","unstructured":"Br\u00e4ndle, D. et al. The shared tumor-specific antigen encoded by mouse gene P1A is a target not only for cytolytic T lymphocytes but also for tumor rejection. Eur. J. Immunol. 28, 4010\u20134019 (1998).","journal-title":"Eur. J. Immunol."},{"key":"BFnm934_CR15","doi-asserted-by":"publisher","first-page":"11515","DOI":"10.1073\/pnas.201398198","volume":"98","author":"JP Medema","year":"2001","unstructured":"Medema, J.P. et al. Blockade of the granzyme B\/perforin pathway through overexpression of the serine protease inhibitor PI-9\/SPI-6 constitutes a mechanism for immune escape by tumors. Proc. Natl. Acad. Sci. USA 98, 11515\u201311520 (2001).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm934_CR16","first-page":"97","volume":"11","author":"G Pawelec","year":"2000","unstructured":"Pawelec, G. et al. Escape mechanisms in tumor immunity: a year 2000 update. Crit. Rev. Oncog. 11, 97\u2013133 (2000).","journal-title":"Crit. Rev. Oncog."},{"key":"BFnm934_CR17","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0065-2776(08)60911-6","volume":"74","author":"F Marincola","year":"2000","unstructured":"Marincola, F., Jaffee, E.M., Hicklin, D.J. & Ferrone, S. Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance. Adv. Immunol. 74, 181\u2013273 (2000).","journal-title":"Adv. Immunol."},{"key":"BFnm934_CR18","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/0003-9861(91)90142-6","volume":"291","author":"SG Cady","year":"1991","unstructured":"Cady, S.G. & Sono, M. 1-Methyl-DL-tryptophan, \u03b2-(3-benzofuranyl)-DL-alanine (the oxygen analog of tryptophan), and \u03b2-[3-benzo(b)thienyl]-DL-alanine (the sulfur analog of tryptophan) are competitive inhibitors for indoleamine 2,3-dioxygenase. Arch. Biochem. Biophys. 291, 326\u2013333 (1991).","journal-title":"Arch. Biochem. Biophys."},{"key":"BFnm934_CR19","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S0925-4439(99)00096-4","volume":"1500","author":"Y Kudo","year":"2000","unstructured":"Kudo, Y. & Boyd, C.A. Human placental indoleamine 2,3-dioxygenase: cellular localization and characterization of an enzyme preventing fetal rejection. Biochim. Biophys. Acta 1500, 119\u2013124 (2000).","journal-title":"Biochim. Biophys. Acta"},{"key":"BFnm934_CR20","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/j.1469-7793.2001.0405i.x","volume":"531","author":"Y Kudo","year":"2001","unstructured":"Kudo, Y. & Boyd, C.A. Characterisation of L-tryptophan transporters in human placenta: a comparison of brush border and basal membrane vesicles. J. Physiol. 531, 405\u2013416 (2001).","journal-title":"J. Physiol."},{"key":"BFnm934_CR21","doi-asserted-by":"publisher","first-page":"13136","DOI":"10.1021\/bi001512t","volume":"39","author":"M Pr\u00e6torius-Ibba","year":"2000","unstructured":"Pr\u00e6torius-Ibba, M. et al. Ancient adaptation of the active site of tryptophanyl-tRNA synthetase for tryptophan binding. Biochemistry 39, 13136\u201313143 (2000).","journal-title":"Biochemistry"},{"key":"BFnm934_CR22","doi-asserted-by":"publisher","first-page":"16820","DOI":"10.1074\/jbc.275.22.16820","volume":"275","author":"R Jorgensen","year":"2000","unstructured":"Jorgensen, R., Sogaard, T.M.M., Rossing, A.B., Martensen, P.M. & Justesen, J. Identification and characterization of human mitochondrial tryptophanyl-tRNA synthetase. J. Biol. Chem. 275, 16820\u201316826 (2000).","journal-title":"J. Biol. Chem."},{"key":"BFnm934_CR23","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1084\/jem.20020052","volume":"196","author":"P Terness","year":"2002","unstructured":"Terness, P. et al. Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites. J. Exp. Med. 196, 447\u2013457 (2002).","journal-title":"J. Exp. Med."},{"key":"BFnm934_CR24","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/sj.cdd.4401073","volume":"9","author":"F Fallarino","year":"2002","unstructured":"Fallarino, F. et al. T cell apoptosis by tryptophan catabolism. Cell Death Differ. 9, 1069\u20131077 (2002).","journal-title":"Cell Death Differ."},{"key":"BFnm934_CR25","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/S0952-7915(97)80050-7","volume":"9","author":"B Van den Eynde","year":"1997","unstructured":"Van den Eynde, B. & van der Bruggen, P. T cell-defined tumor antigens. Curr. Opin. Immunol. 9, 684\u2013693 (1997).","journal-title":"Curr. Opin. Immunol."},{"key":"BFnm934_CR26","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0952-7915(03)00010-4","volume":"15","author":"T Boon","year":"2003","unstructured":"Boon, T. & Van den Eynde, B. Tumor immunology\u2014editorial overview. Curr. Opin. Immunol. 15, 129\u2013130 (2003).","journal-title":"Curr. Opin. Immunol."},{"key":"BFnm934_CR27","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/nm0398-328","volume":"4","author":"FO Nestle","year":"1998","unstructured":"Nestle, F.O. et al. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nat. Med. 4, 328\u2013332 (1998).","journal-title":"Nat. Med."},{"key":"BFnm934_CR28","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nm0398-321","volume":"4","author":"SA Rosenberg","year":"1998","unstructured":"Rosenberg, S.A. et al. Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma. Nat. Med. 4, 321\u2013327 (1998).","journal-title":"Nat. Med."},{"key":"BFnm934_CR29","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1002\/(SICI)1097-0215(19990118)80:2<219::AID-IJC10>3.0.CO;2-S","volume":"80","author":"M Marchand","year":"1999","unstructured":"Marchand, M. et al. Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1. Int. J. Cancer 80, 219\u2013230 (1999).","journal-title":"Int. J. Cancer"},{"key":"BFnm934_CR30","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1084\/jem.190.11.1669","volume":"190","author":"B Thurner","year":"1999","unstructured":"Thurner, B. et al. Vaccination with MAGE-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma. J. Exp. Med. 190, 1669\u20131678 (1999).","journal-title":"J. Exp. Med."},{"key":"BFnm934_CR31","doi-asserted-by":"publisher","first-page":"12198","DOI":"10.1073\/pnas.220413497","volume":"97","author":"E J\u00e4ger","year":"2000","unstructured":"J\u00e4ger, E. et al. Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers. Proc. Natl. Acad. Sci. USA 97, 12198\u201312203 (2000).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm934_CR32","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1042\/bj3550425","volume":"355","author":"S Suzuki","year":"2001","unstructured":"Suzuki, S. et al. Expression of indoleamine 2,3-dioxygenase and tryptophan 2,3- dioxygenase in early concepti. Biochem. J. 355, 425\u2013429 (2001).","journal-title":"Biochem. J."},{"key":"BFnm934_CR33","first-page":"2531","volume":"38","author":"T Uno","year":"1997","unstructured":"Uno, T., Chen, P.W., Murray, T.G., Podack, E.R. & Ksander, B.R. Gene transfer of the CD80 costimulatory molecule into ocular melanoma cells using a novel episomal vector. Invest. Ophtalmol. Vis. Sci. 38, 2531\u20132539 (1997).","journal-title":"Invest. Ophtalmol. Vis. Sci."},{"key":"BFnm934_CR34","first-page":"3202","volume":"40","author":"H Wenkel","year":"1999","unstructured":"Wenkel, H., Chen, P.W., Ksander, B.R. & Streilein, J.W. Immune privilege is extended, then withdrawn, from allogeneic tumor cell grafts placed in the subretinal space. Invest. Opthalmol. Vis. Sci. 40, 3202\u20133208 (1999).","journal-title":"Invest. Opthalmol. Vis. Sci."},{"key":"BFnm934_CR35","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1002\/eji.1830220916","volume":"22","author":"B Leth\u00e9","year":"1992","unstructured":"Leth\u00e9, B., Van den Eynde, B., Van Pel, A., Corradin, G. & Boon, T. Mouse tumor rejection antigens P815A and P815B: two epitopes carried by a single peptide. Eur. J. Immunol. 22, 2283\u20132288 (1992).","journal-title":"Eur. J. Immunol."},{"key":"BFnm934_CR36","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/BF01534840","volume":"11","author":"A Van Pel","year":"1985","unstructured":"Van Pel, A., De Plaen, E. & Boon, T. Selection of a highly transfectable variant from mouse mastocytoma P815. Som. Cell Genet. 11, 467\u2013475 (1985).","journal-title":"Som. Cell Genet."},{"key":"BFnm934_CR37","doi-asserted-by":"publisher","first-page":"3053","DOI":"10.4049\/jimmunol.169.6.3053","volume":"169","author":"J Bilsborough","year":"2002","unstructured":"Bilsborough, J. et al. TNF-mediated toxicity after massive induction of specific CD8+ T cells following immunization of mice with a tumor-specific peptide. J. Immunol. 169, 3053\u20133060 (2002).","journal-title":"J. Immunol."},{"key":"BFnm934_CR38","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1084\/jem.182.3.689","volume":"182","author":"B Van den Eynde","year":"1995","unstructured":"Van den Eynde, B. et al. A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma. J. Exp. Med. 182, 689\u2013698 (1995).","journal-title":"J. Exp. Med."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm934.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm934","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm934.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T18:35:17Z","timestamp":1684434917000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm934"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,9,21]]},"references-count":38,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2003,10]]}},"alternative-id":["BFnm934"],"URL":"https:\/\/doi.org\/10.1038\/nm934","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1015893.199102","asserted-by":"object"}]},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,9,21]]}}}